A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
Shandong Suncadia Medicine Co., Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
Verastem, Inc.
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc.
Hoffmann-La Roche
Eli Lilly and Company
Alliance for Clinical Trials in Oncology
NRG Oncology
Novartis
Pfizer
Sun Yat-sen University
University of Virginia
Hoffmann-La Roche
SWOG Cancer Research Network
Pfizer
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Fudan University
AstraZeneca
NRG Oncology
Institute of Cancer Research, United Kingdom
Rovi Pharmaceuticals Laboratories
Tolmar Inc.
Tolmar Inc.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
UNICANCER
Pfizer
Swiss GO Trial Group
UNICANCER
Stemline Therapeutics, Inc.
Sanofi
European Organisation for Research and Treatment of Cancer - EORTC
Xuanzhu Biopharmaceutical Co., Ltd.
AstraZeneca
National Cancer Institute (NCI)
University of California, San Francisco
SOLTI Breast Cancer Research Group
Alliance for Clinical Trials in Oncology
Region Örebro County